Preliminary Study of Uterine Healing After Caesarean Section: CLInico-ECHOgraphic and Anatomopathologic COrrelation

NCT ID: NCT05785559

Last Updated: 2023-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

90 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-01

Study Completion Date

2024-07-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Caesarean section is one of the most common surgical procedures. The multiplication of uterine scars leads to an increase in complications and in particular those related to poor healing such as isthmocele or uterine rupture.

The processes of uterine healing at the histological scale are little known. The main objective of the research is to analyze the process of uterine healing by means of uterine biopsies performed on the areas of cesarean section scars.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Our hypothesis is that there is a histological healing defect visible on an anatomopathologic examination of the scar. This poor uterine healing on histological scale is probably associated with uterine healing defects visible on pelvic ultrasound (scar dehiscence) and clinical criteria (number of caesareans, symptoms).

The objective of the research is to analyze uterine scarring by means of uterine biopsies performed on the areas of cesarean section scars. The uterine scarred areas will be analyzed histologically according to specific criteria and compared to healthy uterine areas. Histological characteristics will be compared with clinical and ultrasound data.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Assessment of Uterine Healing

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Uterine biopsy and cesarean scar dehiscence
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Scarred uterus

Patients who have already undergone one or more cesarean section(s) during a previous pregnancy and for whom a cesarean section is indicated on a scheduled or emergency basis.

Group Type EXPERIMENTAL

uterine biopsies

Intervention Type PROCEDURE

uterine biopsies performed on the areas of cesarean section scars

Scar dehiscence surgery

Patients who have already undergone one or more caesarean section(s) and for whom the surgical management of a dehiscence of a caesarean section scar is indicated outside of pregnancy.

Group Type EXPERIMENTAL

uterine biopsies

Intervention Type PROCEDURE

uterine biopsies performed on the areas of cesarean section scars

Healthy uterus

Patients with no history of caesarean section, pregnant with an indication for caesarean section: patients who have never had a caesarean section during a previous pregnancy or who are pregnant with their first pregnancy and for whom a caesarean section is indicated scheduled or urgently"

Group Type EXPERIMENTAL

uterine biopsies

Intervention Type PROCEDURE

uterine biopsies performed on the areas of cesarean section scars

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

uterine biopsies

uterine biopsies performed on the areas of cesarean section scars

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Common to all groups:
* Adult patient,
* Signed consent for participation in the study
* Patient affiliated to a social security scheme (excluding AME)

Group 1:

* Support for a scheduled or emergency caesarean (excluding patients having an emergency caesarean (red code: caesarean within 15 minutes))
* Scarred uterus: having already benefited from a caesarean section

Group 2:

\- Surgical management of caesarean section scar dehiscence after a caesarean section

Group 3 (control):

* Support for a scheduled or emergency caesarean (excluding patients having an emergency caesarean (red code: caesarean within 15 minutes)
* Healthy uterus: no history of caesarean section (history of vaginal delivery or first pregnancy)

Exclusion Criteria

* Disorder of hemostasis at risk of bleeding
* Anatomopathological sampling not feasible
* Patient with a history of upper genital infections
* Patient under legal protection (guardianship, curatorship)
* Patient who does not speak or understand French
* Patient unable to answer questions or with difficulty in expressing herself
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Assistance Publique - Hôpitaux de Paris

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Perrine CAPMAS

Role: PRINCIPAL_INVESTIGATOR

APHP

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AP-HP, Bicêtre Hospital

Le Kremlin-Bicêtre, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Perrine CAPMAS

Role: CONTACT

0145217714

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

APHP220952

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.